Cork Planning Application from ALTANA Pharma
This EUR70 million investment in a high-value tablet making facility at Carrigtwohill will create a major global source for ALTANA Pharma products. The 11 hectare site will be the only one in Europe outside of Germany focussing on worldwide tablet supply.
The investment, which was announced by the Tanaiste, Ms Mary Harney, T.D. on behalf of IDA Ireland in March, has been prompted mainly by the Altana Pharma Group's strong international growth, which requires capital expenditure in two key areas to support it. In addition to the Irish location the Group also intends to expand an existing site near Berlin.
A statement said the EUR70 million initial investment will establish a high-value operation at Carrigtwohill. The company will create up to 150 new jobs for highly skilled staff, the majority of whom will be recruited in Ireland. The new facility will play an important role in the company's future development.
The Carrigtwohill site will initially produce tablets for one of the company's drugs, Roflumilast, for the treatment of chronic obstructive pulmonary disease (COPD) and asthma following full regulatory approval.
A second medicine, Pantoprazole (Protiumţ), the most successful drug of ALTANA Pharma, which is used in over 90 countries to treat acid-induced gastrointestinal conditions and oesophagitis, will also be produced.
Subject to planning approval, ALTANA Pharma hopes to begin construction by the end of this year and commence production for market supply in 2006.
In 2002 ALTANA Pharma, which is headquartered in Konstanz, Germany, achieved EUR1.9 billion in sales; had more than 7,500 employees and spent EUR335 million on research. It has more than 30 subsidiaries and affiliates throughout Europe, the Americas, South Africa, Australia and Asia.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.